jRCT2071260067招募中不适用
ONO-3401-01: A Phase I, Placebo-controlled, Double-Blind, Randomized, Parallel-Group Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of ONO - 3401 in Japanese Healthy Adult Male Participants
未提供0 个研究点目标入组 66 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 45age old under（—）
- 性别
- Male
入选标准
- •Japanese healthy adult male Participants
- •Age at the time of informed consent: 18 to 45
- •BMI (at screening): 18.5 kg/m2 to less than 25.0 kg/m2
排除标准
- •Subjects who currently receive treatment for or have a history of any of the following diseases: respiratory system, cardiovascular system, psychiatric system, nervous system, gastrointestinal system, immune system, liver, kidney, hematopoietic function, or endocrine function.
- •The participant has a lifetime history of suicidal ideation or suicide attempt.
- •Presence or history of severe allergy to drugs or food
- •Presence or history of drug or alcohol dependence
研究者
相似试验
招募中
不适用
ONO-2416-01: A phase I study to evaluate the safety, tolerability, and pharmacokinetics of ONO-2416 in Japanese healthy adult male subjectsHealthy volunteers(The planned indication has not been determined.)jRCT207125014786
招募中
不适用
A Phase 2 study of naldemedine in participants with constipation associated with Parkinson's diseasejRCT203126006040
招募中
不适用
An Investigator-Initiated Phase II Clinical Trial of a Therapeutic Agent for Clozapine-Induced SialorrheaClozapine-induced sialorrheajRCT203126006530
招募中
1 期
A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Dose-Ranging Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CTX611 in Healthy Adult ParticipantsThromboembolic disorders2026-526708-56-00CRISPR Therapeutics AG48
招募中
不适用
A phase 3 study of TS-172 in hyperphosphatemia patients on hemodialysis with phosphate bindersHyperphosphatemiajRCT2031250548100